Literature DB >> 3760142

Detection of elevated levels of 2-5A synthetase in serum from children with various infectious diseases.

H Sugino, I Mitani, M Koike, T Kodama, J Sokawa, H Sawai, K Ishibashi, M Itoh, S Watanabe, Y Sokawa.   

Abstract

By a sensitive radioimmunoassay method, (2'-5')oligoadenylate synthetase was detected in serum from patients with viral, bacterial, or mycoplasmal infections at elevated levels compared with enzyme levels in serum from healthy individuals and patients suffering from noninfectious diseases.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3760142      PMCID： PMC268943          DOI： 10.1128/jcm.24.3.478-481.1986

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  17 in total

1.  pppA2'p5'A2'p5'A: an inhibitor of protein synthesis synthesized with an enzyme fraction from interferon-treated cells.

Authors:  I M Kerr; R E Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1978-01       Impact factor: 11.205

2.  Clinical value of the determination of an interferon-induced enzyme activity: studies of the 2'5' oligoadenylate synthetase activity in peripheral blood lymphocytes of patients.

Authors:  S Chousterman; M Chousterman; P Reinert; M N Thang
Journal:  Biomed Pharmacother       Date:  1983       Impact factor: 6.529

3.  Assay and the levels of 2-5A-synthetase in lymphocytes of patients with viral, bacterial and autoimmune diseases.

Authors:  C Buffet-Janvresse; H Magard; N Robert; A G Hovanessian
Journal:  Ann Immunol (Paris)       Date:  1983 Sep-Oct

4.  Enzymology of interferon action--a short survey.

Authors:  P Lengyel
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

5.  Interferon inducers: general survey and classification.

Authors:  P F Torrence; E De Clercq
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

6.  Assay of an interferon-induced enzyme in white blood cells as a diagnostic aid in viral diseases.

Authors:  A Schattner; D Wallach; G Merlin; T Hahn; S Levin; M Revel
Journal:  Lancet       Date:  1981-09-05       Impact factor: 79.321

7.  2'5' oligo(A) polymerase activity in serum of mice infected with EMC virus or treated with interferon.

Authors:  I Krishnan; C Baglioni
Journal:  Nature       Date:  1980-06-12       Impact factor: 49.962

8.  Induction of 2',5'-oligoadenylate synthetase and interferon in mouse trigeminal ganglia infected with herpes simplex virus.

Authors:  Y Sokawa; T Ando; Y Ishihara
Journal:  Infect Immun       Date:  1980-06       Impact factor: 3.441

9.  Monitoring of interferon therapy by assay of (2'--5') oligo-isoadenylate synthetase in human peripheral white blood cells.

Authors:  A Schattner; G Merlin; D Wallach; H Rosenberg; T Bino; T Hahn; S Levin; M Revel
Journal:  J Interferon Res       Date:  1981

10.  Sensitive radioimmuno assay for 2',5'-oligoadenylates using a novel 125I-labeled derivative of 2',5'-triadenylate 5'-triphosphate.

Authors:  H Sawai; K Ishibashi; M Itoh; S Watanabe
Journal:  J Biochem       Date:  1985-10       Impact factor: 3.387
View more
  6 in total

1.  Induction and measurement of 2',5'-oligoadenylate synthetase in Madin-Darby bovine kidney cells and in cattle.

Authors:  E C Short; R W Fulton
Journal:  J Clin Microbiol       Date:  1987-09       Impact factor: 5.948

2.  Detection of 2',5' oligoadenylate synthetase activity in acute viral hepatitis with special reference to histologic features in the acute stage.

Authors:  T Okuno; M Shindo; K Arai; M Matsumoto; M Takeda; K Kashima; Y Sokawa
Journal:  Gastroenterol Jpn       Date:  1991-04

3.  Alpha-Interferon for the treatment of idiopathic sudden sensorineural hearing loss.

Authors:  S Kanemaru; H Fukushima; H Nakamura; H Tamaki; Y Fukuyama; Y Tamura
Journal:  Eur Arch Otorhinolaryngol       Date:  1997       Impact factor: 2.503

4.  Biochemical and immunological responses of hairy cell leukemia patients to interferon beta.

Authors:  A M Liberati; M Horisberger; M Schippa; F Di Clemente; M Fizzotti; S Filippo; M G Proietti; S Arzano; P Berruto; L Palmisano
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

5.  2',5' Oligoadenylate synthetase activity in peripheral blood mononuclear cells and serum during interferon treatment of chronic non-A, non-B hepatitis.

Authors:  T Okuno; M Shindo; K Arai; M Matsumoto; M Takeda; K Kashima; Y Sokawa
Journal:  Gastroenterol Jpn       Date:  1991-10

6.  Decreased interferon binding capacity of peripheral blood mononuclear cells during interferon treatment of chronic hepatitis B with special reference to (2'-5') oligoadenylate synthetase activity.

Authors:  M Shindo; A Iwata; T Okuno; M Matsumoto; M Takeda; K Arai; Y Sokawa
Journal:  Gastroenterol Jpn       Date:  1989-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.